IBDEI0CN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5658,0)
 ;;=357.2^^28^373^15
 ;;^UTILITY(U,$J,358.3,5658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5658,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,5658,1,4,0)
 ;;=4^POLYNEUROPATHY IN DM
 ;;^UTILITY(U,$J,358.3,5658,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,5659,0)
 ;;=581.81^^28^373^14
 ;;^UTILITY(U,$J,358.3,5659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5659,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,5659,1,4,0)
 ;;=4^NEPHROTIC SYN IN OTH DIS
 ;;^UTILITY(U,$J,358.3,5659,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,5660,0)
 ;;=276.2^^28^374^1
 ;;^UTILITY(U,$J,358.3,5660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5660,1,3,0)
 ;;=3^276.2
 ;;^UTILITY(U,$J,358.3,5660,1,4,0)
 ;;=4^ACIDOSIS
 ;;^UTILITY(U,$J,358.3,5660,2)
 ;;=^2070
 ;;^UTILITY(U,$J,358.3,5661,0)
 ;;=276.3^^28^374^2
 ;;^UTILITY(U,$J,358.3,5661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5661,1,3,0)
 ;;=3^276.3
 ;;^UTILITY(U,$J,358.3,5661,1,4,0)
 ;;=4^ALKALOSIS
 ;;^UTILITY(U,$J,358.3,5661,2)
 ;;=^4889
 ;;^UTILITY(U,$J,358.3,5662,0)
 ;;=276.51^^28^374^3
 ;;^UTILITY(U,$J,358.3,5662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5662,1,3,0)
 ;;=3^276.51
 ;;^UTILITY(U,$J,358.3,5662,1,4,0)
 ;;=4^DEHYDRATION
 ;;^UTILITY(U,$J,358.3,5662,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,5663,0)
 ;;=253.5^^28^374^4
 ;;^UTILITY(U,$J,358.3,5663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5663,1,3,0)
 ;;=3^253.5
 ;;^UTILITY(U,$J,358.3,5663,1,4,0)
 ;;=4^DIABETES INSIPIDUS
 ;;^UTILITY(U,$J,358.3,5663,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,5664,0)
 ;;=276.9^^28^374^5
 ;;^UTILITY(U,$J,358.3,5664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5664,1,3,0)
 ;;=3^276.9
 ;;^UTILITY(U,$J,358.3,5664,1,4,0)
 ;;=4^ELECTROLYTE DISORDER NOS
 ;;^UTILITY(U,$J,358.3,5664,2)
 ;;=^267949
 ;;^UTILITY(U,$J,358.3,5665,0)
 ;;=276.69^^28^374^6
 ;;^UTILITY(U,$J,358.3,5665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5665,1,3,0)
 ;;=3^276.69
 ;;^UTILITY(U,$J,358.3,5665,1,4,0)
 ;;=4^FLUID OVERLOAD NEC
 ;;^UTILITY(U,$J,358.3,5665,2)
 ;;=^339607
 ;;^UTILITY(U,$J,358.3,5666,0)
 ;;=275.42^^28^374^8
 ;;^UTILITY(U,$J,358.3,5666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5666,1,3,0)
 ;;=3^275.42
 ;;^UTILITY(U,$J,358.3,5666,1,4,0)
 ;;=4^HYPERCALCEMIA
 ;;^UTILITY(U,$J,358.3,5666,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,5667,0)
 ;;=276.0^^28^374^9
 ;;^UTILITY(U,$J,358.3,5667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5667,1,3,0)
 ;;=3^276.0
 ;;^UTILITY(U,$J,358.3,5667,1,4,0)
 ;;=4^HYPERNATREMIA
 ;;^UTILITY(U,$J,358.3,5667,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,5668,0)
 ;;=276.7^^28^374^10
 ;;^UTILITY(U,$J,358.3,5668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5668,1,3,0)
 ;;=3^276.7
 ;;^UTILITY(U,$J,358.3,5668,1,4,0)
 ;;=4^HYPERPOTASSEMIA/HYPERKALEMIA
 ;;^UTILITY(U,$J,358.3,5668,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,5669,0)
 ;;=275.41^^28^374^11
 ;;^UTILITY(U,$J,358.3,5669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5669,1,3,0)
 ;;=3^275.41
 ;;^UTILITY(U,$J,358.3,5669,1,4,0)
 ;;=4^HYPOCALCEMIA
 ;;^UTILITY(U,$J,358.3,5669,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,5670,0)
 ;;=588.89^^28^374^12
 ;;^UTILITY(U,$J,358.3,5670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5670,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,5670,1,4,0)
 ;;=4^HYPOKALEMIC NEPHROPATHY
 ;;^UTILITY(U,$J,358.3,5670,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,5671,0)
 ;;=276.1^^28^374^13
 ;;^UTILITY(U,$J,358.3,5671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5671,1,3,0)
 ;;=3^276.1
 ;;^UTILITY(U,$J,358.3,5671,1,4,0)
 ;;=4^HYPONATREMIA
 ;;^UTILITY(U,$J,358.3,5671,2)
 ;;=^60722
 ;;^UTILITY(U,$J,358.3,5672,0)
 ;;=275.3^^28^374^14
 ;;^UTILITY(U,$J,358.3,5672,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0CN
